A Study to Learn About the Study Medicines (Nirmatrelvir Plus Ritonavir) in People Aged 12 Years or Older With COVID-19 and a Compromised Immune System

PHASE2CompletedINTERVENTIONAL
Enrollment

158

Participants

Timeline

Start Date

August 3, 2022

Primary Completion Date

July 17, 2023

Study Completion Date

November 13, 2023

Conditions
COVID-19
Interventions
DRUG

Nirmatrelvir

Participants will receive 2 tablets of nirmatrelvir every 12 hours

DRUG

Ritonavir

Participants will receive 1 capsule of ritonavir every 12 hours

DRUG

Placebo for nirmatrelvir

Participants will receive 2 tablets of placebo for nirmatrelvir every 12 hours. A placebo does not have any medicine in it but looks just like the medicine being studied.

DRUG

Placebo for ritonavir

Participants will receive 1 capsule of placebo for ritonavir every 12 hours. A placebo does not have any medicine in it but looks just like the medicine being studied.

Trial Locations (84)

1097

Dél-Pesti Centrumkórház Országos Hematológiai és infektológiai intézet, Szent László telep, Budapest

1122

Semmelweis Egyetem, Budapest

1606

Military Medical Academy, Sofia

2000

MHAT Samokov, Samokov

3000

Peter MacCallum Cancer Centre, Melbourne

3050

The Royal Melbourne Hospital, Parkville

3052

Royal Melbourne Hospital - Royal Park Campus, Parkville

3600

Diagnostic Consultative Center - 1 Lom EOOD, Lom

4000

Medical Center Artmed, Plovdiv

MHAT Sveta Karidad EAD, Plovdiv

4400

Medifarma 98 Kft, Nyíregyháza

5804

MHAT - Heart and Brain, Pleven

6305

Specialized Hospital for Active Treatment of Pneumo-Phthisiatric Diseases - Haskovo EOOD, Haskovo

10029

Icahn School of Medicine at Mount Sinai, New York

14080

Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City

15006

CHUAC-Complejo Hospitalario Universitario A Coruña, A Coruña

20007

Georgetown University Medical Center, Washington D.C.

20892

National Institute of Health, Bethesda

28034

Hospital Universitario Ramón y Cajal, Madrid

28046

Hospital Universitario La Paz, Madrid

30322

Emory University Hospital-Georgia Clinical Research Center, Atlanta

Emory University School of Medicine, Atlanta

The Emory Clinic, Atlanta

33010

Qway Research LLC, Hialeah

33064

NAPA Research, Pompano Beach

33126

I.V.A.M. Clinical & Investigational Center, Doral

Premium Medical Research Corp, Miami

33135

Global Health Clinical Trials, Miami

33144

I.V.A.M. Clinical & Investigational Center, Miami

33615

Santos Research Center, Tampa

34000

Instituto de Investigaciones Clínicas para la Salud, Durango

36312

CHUVI- Hospital Alvaro Cunqueiro, Vigo

37007

Hospital Universitario de Salamanca - Complejo Asistencial Universitario de Salamanca, Salamanca

41014

Hospital Universitario Virgen de Valme, Seville

46010

Hospital Clinico de Valencia, Valencia

Hospital Clinico Universitario Valencia, Valencia

46026

Hospital Universitari i Politecnic La Fe, Valencia

48073

Beaumont Infectious Diseases Research, Royal Oak

48109

University of Michigan, Ann Arbor

48312

Revival Research Institute, Sterling Heights

64506

MediSearch Clinical Trials, Saint Joseph

66460

"Hospital Universitario Dr. Jose Eleuterio Gonzalez", Monterrey

68000

Oaxaca Site Management Organization S.C., Oaxaca City

75246

Baylor University Medical Center, Dallas

North Texas Infectious Diseases Consultants, P.A, Dallas

76104

Texas Centers for Infectious Disease Associates, Fort Worth

78404

South Texas Clinical Research, Corpus Christi

91851

Instituto Veracruzano en Investigación Clínica S.C., Veracruz

91900

FAICIC S. de R.L. de C.V., Veracruz

94143

CRS Outpatient Services UCSF, San Francisco

UCSF Helen Diller Medical Center at Parnassus Heights, San Francisco

UCSf infectious disease Lab, San Francisco

97000

EME RED Hospitalaria, Mérida

98109

Fred Hutchinson Cancer Center - COVID Clinical Research Center, Seattle

15090000

Fundação Faculdade Regional de Medicina de São José do Rio Preto, São José do Rio Preto

17201130

CECIP - Centro de Estudos do Interior Paulista, Jaú

59025050

Centro de Estudos e Pesquisa em Molestias Infecciosas - CPCLIN/RN, Natal

20241-180

IBPClin - Instituto Brasil de Pesquisa Clínica, Rio de Janeiro

21040-360

Instituto Nacional de Infectologia Evandro Chagas, Rio de Janeiro

V6Z 2C7

Vancouver Infectious Diseases Centre, Vancouver

N1H 1B1

Dawson Clinical Research, Guelph

L8N 4A6

St. Joseph's Healthcare Hamilton, Hamilton

M9V 4B4

Dr. Anil K. Gupta Medicine Professional Corporation, Toronto

K0C 2K0

Winchester District Memorial Hospital, Winchester

G7H 7Y8

INTERMED Groupe Sante, Chicoutimi

H2L 4P9

Clinique Medicale lActuel, Montreal

J1L 0H8

Diex Recherche Sherbrooke Inc., Sherbrooke

Diex Recherche Trois-Rivieres Inc., Sherbrooke

979 01

REUMEX s.r.o., Rimavská Sobota

833 10

Narodny onkologicky ustav, Bratislava

955 01

ALERGIA s.r.o., Topoľčany

ALERGIA s.r.o., Topoľčany

01852

MUDr. Viliam Cibik, PhD., s.r.o., Pruské

851 07

Univerzitna nemocnica Bratislava - Nemocnica sv. Cyrila a Metoda, Bratislava

Univerzitná nemocnica Bratislava, Nemocnica sv. Cyrila a Metoda, Bratislava

04011

ARTROMAC n. o., Košice

080 01

MEDIKOMP, s.r.o, Prešov

052 01

Plucna ambulancia Hrebenar s.r.o., Spišská Nová Ves

Plucna ambulancia Hrebenar, s.r.o., Spišská Nová Ves

089 01

SANARE spol.s.r.o., Svidník

08916

Hospital Germans Trias i Pujol, Badalona

08036

Hospital Clínic de Barcelona, Barcelona

08041

Hospital de la Santa Creu i Sant Pau, Barcelona

08035

Hospital Universitari Vall d'Hebron, Barcelona

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT05438602 - A Study to Learn About the Study Medicines (Nirmatrelvir Plus Ritonavir) in People Aged 12 Years or Older With COVID-19 and a Compromised Immune System | Biotech Hunter | Biotech Hunter